IGF1R and head and neck squamous cell carcinoma: Our previous work demonstrated that inhibition of insulin-like growth factor-1 receptor (IGF1R) with BMS754807 in combination with Src family kinase inhibition by dasatinib synergistically inhibits growth of HPV− HNSCC cells in vitro5.